Kyowa Kirin, the Japanese Specialty Pharmaceutical Firm, is Considering a Sale of Some of ... - Latest Tweet by Bloomberg
The latest Tweet by Bloomberg states, 'Kyowa Kirin, the Japanese specialty pharmaceutical firm, is considering a sale of some of its international assets that could fetch about $1 billion, sources say ...'
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)